138 related articles for article (PubMed ID: 9925371)
1. Angiotensin AT1 receptor inhibition in pacing induced heart failure: effects on left ventricular myocardial collagen content and composition.
Clair MJ; Krombach RS; Coker ML; Heslin TL; Kribbs SB; de Gasparo M; Spinale FG
J Mol Cell Cardiol; 1998 Nov; 30(11):2355-64. PubMed ID: 9925371
[TBL] [Abstract][Full Text] [Related]
2. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II subtype-1 receptor blockade during the development of left ventricular hypertrophy in dogs: effects on ventricular and myocyte function.
Spinale FG; Holzgrefe HH; Walker JD; Mukherjee R; Kribbs SB; Powell JR; Antonaccio M
J Cardiovasc Pharmacol; 1997 Nov; 30(5):623-31. PubMed ID: 9388045
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin AT1 receptor inhibition, angiotensin-converting enzyme inhibition, and combination therapy with developing heart failure: cellular mechanisms of action.
Spinale FG; Iannini JP; Mukherjee R; Melton DM; de Gasparo M
J Card Fail; 1998 Dec; 4(4):325-32. PubMed ID: 9924854
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition and angiotensin II subtype-1 receptor blockade during the progression of left ventricular dysfunction: differential effects on myocyte contractile processes.
Spinale FG; Holzgrefe HH; Mukherjee R; Webb ML; Hird RB; Cavallo MJ; Powell JR; Koster WH
J Pharmacol Exp Ther; 1997 Dec; 283(3):1082-94. PubMed ID: 9399980
[TBL] [Abstract][Full Text] [Related]
9. Effects of combined angiotensin II and endothelin receptor blockade with developing heart failure: effects on left ventricular performance.
New RB; Sampson AC; King MK; Hendrick JW; Clair MJ; McElmurray JH; Mandel J; Mukherjee R; de Gasparo M; Spinale FG
Circulation; 2000 Sep; 102(12):1447-53. PubMed ID: 10993866
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase inhibition during the development of congestive heart failure : effects on left ventricular dimensions and function.
Spinale FG; Coker ML; Krombach SR; Mukherjee R; Hallak H; Houck WV; Clair MJ; Kribbs SB; Johnson LL; Peterson JT; Zile MR
Circ Res; 1999 Aug; 85(4):364-76. PubMed ID: 10455065
[TBL] [Abstract][Full Text] [Related]
11. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure.
Cheng CP; Suzuki M; Ohte N; Ohno M; Wang ZM; Little WC
Circ Res; 1996 May; 78(5):880-92. PubMed ID: 8620609
[TBL] [Abstract][Full Text] [Related]
12. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
Spinale FG; Johnson WS; Wang Y; Wang Z; Mukherjee R; Hebbar L; Jones BU
J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
[TBL] [Abstract][Full Text] [Related]
13. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure: relation to ventricular and myocyte function.
Spinale FG; Coker ML; Thomas CV; Walker JD; Mukherjee R; Hebbar L
Circ Res; 1998 Mar; 82(4):482-95. PubMed ID: 9506709
[TBL] [Abstract][Full Text] [Related]
14. Selective vasopressin, angiotensin II, or dual receptor blockade with developing congestive heart failure.
Clair MJ; King MK; Goldberg AT; Hendrick JW; Nisato R; Gay DM; Morrison AE; McElmurray JH; Krombach RS; Bond BR; Cazaubon C; Nisato D; Spinale FG
J Pharmacol Exp Ther; 2000 Jun; 293(3):852-60. PubMed ID: 10869385
[TBL] [Abstract][Full Text] [Related]
15. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function.
Spinale FG; Walker JD; Mukherjee R; Iannini JP; Keever AT; Gallagher KP
Circulation; 1997 Apr; 95(7):1918-29. PubMed ID: 9107181
[TBL] [Abstract][Full Text] [Related]
16. Treatment with a growth hormone secretagogue in a model of developing heart failure: effects on ventricular and myocyte function.
King MK; Gay DM; Pan LC; McElmurray JH; Hendrick JW; Pirie C; Morrison A; Ding C; Mukherjee R; Spinale FG
Circulation; 2001 Jan; 103(2):308-13. PubMed ID: 11208694
[TBL] [Abstract][Full Text] [Related]
17. Comparison of amlodipine or nifedipine treatment with developing congestive heart failure: effects on myocyte contractility.
McElmurray JH; Mukherjee R; Patterson TM; Goldberg A; King MK; Hendrick JW; Gay DM; Clair MJ; Jolly JR; Spinale FG
J Card Fail; 2001 Jun; 7(2):158-64. PubMed ID: 11420768
[TBL] [Abstract][Full Text] [Related]
18. Effects of growth hormone supplementation on left ventricular morphology and myocyte function with the development of congestive heart failure.
Houck WV; Pan LC; Kribbs SB; Clair MJ; McDaniel GM; Krombach RS; Merritt WM; Pirie C; Iannini JP; Mukherjee R; Spinale FG
Circulation; 1999 Nov; 100(19):2003-9. PubMed ID: 10556227
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
[TBL] [Abstract][Full Text] [Related]
20. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure.
Coker ML; Thomas CV; Clair MJ; Hendrick JW; Krombach RS; Galis ZS; Spinale FG
Am J Physiol; 1998 May; 274(5):H1516-23. PubMed ID: 9612358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
